97 related articles for article (PubMed ID: 12115522)
1. HRAS1 variable number of tandem repeats polymorphism and risk of bladder cancer.
van Gils CH; Conway K; Li Y; Taylor JA
Int J Cancer; 2002 Aug; 100(4):414-8. PubMed ID: 12115522
[TBL] [Abstract][Full Text] [Related]
2. The HRAS1 variable number of tandem repeats and risk of breast cancer.
Tamimi RM; Hankinson SE; Ding S; Gagalang V; Larson GP; Spiegelman D; Colditz GA; Krontiris TG; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1528-30. PubMed ID: 14693748
[TBL] [Abstract][Full Text] [Related]
3. Genetic susceptibility associated with rare HRAS1 variable number of tandem repeats alleles in Spanish non-small cell lung cancer patients.
Rosell R; Calvo R; Sánchez JJ; Maurel J; Guillot M; Monzó M; Núñez L; Barnadas A
Clin Cancer Res; 1999 Jul; 5(7):1849-54. PubMed ID: 10430091
[TBL] [Abstract][Full Text] [Related]
4. Current evidence on the relationship between HRAS1 polymorphism and breast cancer risk: a meta-analysis.
Zhang C; Lv GQ; Yu XM; Gu YL; Li JP; Du LF; Zhou P
Breast Cancer Res Treat; 2011 Jul; 128(2):467-72. PubMed ID: 21221763
[TBL] [Abstract][Full Text] [Related]
5. Hras1 VNTR alleles as susceptibility markers for lung cancer: relationship to microsatellite instability in tumors.
Lindstedt BA; Ryberg D; Zienolddiny S; Khan H; Haugen A
Anticancer Res; 1999; 19(6C):5523-7. PubMed ID: 10697610
[TBL] [Abstract][Full Text] [Related]
6. Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus.
Phelan CM; Rebbeck TR; Weber BL; Devilee P; Ruttledge MH; Lynch HT; Lenoir GM; Stratton MR; Easton DF; Ponder BA; Cannon-Albright L; Larsson C; Goldgar DE; Narod SA
Nat Genet; 1996 Mar; 12(3):309-11. PubMed ID: 8589723
[TBL] [Abstract][Full Text] [Related]
7. An association between the risk of cancer and mutations in the HRAS1 minisatellite locus.
Krontiris TG; Devlin B; Karp DD; Robert NJ; Risch N
N Engl J Med; 1993 Aug; 329(8):517-23. PubMed ID: 8336750
[TBL] [Abstract][Full Text] [Related]
8. The HRAS1 minisatellite locus and risk of ovarian cancer.
Weitzel JN; Ding S; Larson GP; Nelson RA; Goodman A; Grendys EC; Ball HG; Krontiris TG
Cancer Res; 2000 Jan; 60(2):259-61. PubMed ID: 10667571
[TBL] [Abstract][Full Text] [Related]
9. Rare HRAS1 alleles are a risk factor for the development of brain tumors.
Vega A; Sobrido MJ; Ruiz-Ponte C; Barros F; Carracedo A
Cancer; 2001 Dec; 92(11):2920-6. PubMed ID: 11753967
[TBL] [Abstract][Full Text] [Related]
10. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
Okkels H; Sigsgaard T; Wolf H; Autrup H
Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
[TBL] [Abstract][Full Text] [Related]
11. A novel variable number of tandem repeats (VNTR) polymorphism containing Sp1 binding elements in the promoter of XRCC5 is a risk factor for human bladder cancer.
Wang S; Wang M; Yin S; Fu G; Li C; Chen R; Li A; Zhou J; Zhang Z; Liu Q
Mutat Res; 2008 Feb; 638(1-2):26-36. PubMed ID: 17904587
[TBL] [Abstract][Full Text] [Related]
12. [Variable number of tandem repeats polymorphism of MUC20 is associated with the progression of IgA nephropathy].
Li GS; Zhang H; Lü JC; Hou P; Zhou Y; Ma XZ; Wang HY
Zhonghua Yi Xue Za Zhi; 2005 May; 85(19):1333-8. PubMed ID: 16029633
[TBL] [Abstract][Full Text] [Related]
13. HRAS1 minisatellite alleles in colorectal carcinoma: relationship to microsatelite instability.
Vega A; Barros F; Lleonart ME; Ramon y Cajal S; Carracedo A
Anticancer Res; 2001; 21(4A):2855-60. PubMed ID: 11724366
[TBL] [Abstract][Full Text] [Related]
14. HRAS1 rare minisatellite alleles and breast cancer in Australian women under age forty years.
Firgaira FA; Seshadri R; McEvoy CR; Dite GS; Giles GG; McCredie MR; Southey MC; Venter DJ; Hopper JL
J Natl Cancer Inst; 1999 Dec; 91(24):2107-11. PubMed ID: 10601382
[TBL] [Abstract][Full Text] [Related]
15. [Allelotyping the Hras1 minisatellite: formation of carcinogenic risk groups and predicting the course of non-small cell lung cancer].
Chizhikov VV; Gaspar'ian AV; Zborovskaia IB
Genetika; 2001 Oct; 37(10):1388-95. PubMed ID: 11761616
[TBL] [Abstract][Full Text] [Related]
16. [Study of HRas1 minisatellite frequencies in children with thyroid papillary cancer].
Iarmolinskiĭ DG; Kartel NA; Ermak G; Demidchik IuE; Figge J
Tsitol Genet; 2004; 38(1):9-14. PubMed ID: 15098441
[TBL] [Abstract][Full Text] [Related]
17. Aggrecan variable number of tandem repeat polymorphism and lumbar disc degeneration: a meta-analysis.
Gu J; Guan F; Guan G; Xu G; Wang X; Zhao W; Ji Y; Yan J
Spine (Phila Pa 1976); 2013 Dec; 38(25):E1600-7. PubMed ID: 24296484
[TBL] [Abstract][Full Text] [Related]
18. Association of the PIG3 promoter polymorphism with invasive bladder cancer in a Japanese population.
Ito M; Nishiyama H; Watanabe J; Kawanishi H; Takahashi T; Kamoto T; Habuchi T; Ogawa O
Jpn J Clin Oncol; 2006 Feb; 36(2):116-20. PubMed ID: 16418181
[TBL] [Abstract][Full Text] [Related]
19. Interleukin 6 variable number of tandem repeats (VNTR) gene polymorphism in centenarians.
Capurso C; Solfrizzi V; D'Introno A; Colacicco AM; Capurso SA; Semeraro C; Capurso A; Panza F
Ann Hum Genet; 2007 Nov; 71(Pt 6):843-8. PubMed ID: 17506774
[TBL] [Abstract][Full Text] [Related]
20. HLA DRB1, DQB1 and insulin promoter VNTR polymorphisms: interactions and the association with adult-onset diabetes mellitus in Czech patients.
Cejkova P; Novota P; Cerna M; Kolostova K; Novakova D; Kucera P; Novak J; Andel M; Weber P; Zdarsky E
Int J Immunogenet; 2008 Apr; 35(2):133-40. PubMed ID: 18279373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
